QID 160019

Date Published: 2022-08-08

QID 160019: Oracle Enterprise Linux Security Update for mariadb:10.5 (ELSA-2022-5826)

Oracle Enterprise Linux has released a security update for mariadb:10.5 to fix the vulnerabilities.
Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation allows an attacker to compromise the system.

  • CVSS V3 rated as High - 7.8 severity.
  • CVSS V2 rated as Medium - 4.6 severity.
    • Solution
    To resolve this issue, upgrade to the latest packages which contain a patch.Refer to Oracle Enterprise Linux advisory below for updates and patch information:

    ELSA-2022-5826
    Vendor References

    CVEs related to QID 160019

    CVE-2022-27455 | CVE-2022-27456 | CVE-2022-27444 | CVE-2022-27380 | CVE-2022-31622 | CVE-2022-24048 | CVE-2021-46661 | CVE-2022-24050 | CVE-2022-27448 | CVE-2021-46665 | CVE-2022-27383 | CVE-2022-27458 | CVE-2021-46663 | CVE-2022-27384 | CVE-2022-27446 | CVE-2022-24052 | CVE-2022-27387 | CVE-2022-27447 | CVE-2021-46664 | CVE-2022-27451 | CVE-2022-27386 | CVE-2021-46659 | CVE-2022-27382 | CVE-2022-27376 | CVE-2021-46668 | CVE-2022-27378 | CVE-2022-24051 | CVE-2022-27381 | CVE-2022-31623 | CVE-2022-27457 | CVE-2021-46669 | CVE-2022-27452 | CVE-2022-27379 | CVE-2022-27449 | CVE-2022-27377 | CVE-2022-27445 |
    Software Advisories
    Advisory ID Software Component Link
    ELSA-2022-5826 Oracle Linux URL Logo linux.oracle.com/errata/ELSA-2022-5826.html
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].